脳血管調節のダイナミクスとアルツハイマー病の神経画像化現象型
Amaryllis A Tsiknia1, Jamie A Terner1, Zoe E Tsokolas1
1Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 13, 2026
まとめ
脳血管機能を反映した新型の脳血液動力学的マーカーは,高齢者の脳健康と相関しています. これらの発見は,アルツハイマー病 (AD) での血流の役割を支持し,潜在的な臨床応用を示唆しています.
科学分野:
- 神経科学は神経科学である.
- ゲロントロジーはゲロントロジーの学科です.
- 心血管研究 循環器科の研究
背景:
- 脳血管機能障害は,アルツハイマー病 (AD) の病原性に関与しています.
- 脳の血液動力学とADの神経画像マーカーとの関係を理解することは極めて重要です.
研究 の 目的:
- 新規の脳血動力学マーカーとADに関連する神経イメージングフェノタイプとの関連を調査する.
- 高齢者におけるモデルベースの血動力学指標の臨床的有用性を調査する.
主な方法:
- 血圧,CO2,血液の速度,組織の酸素度に関するストキャスティックダイナミックモデルを使用して計算された統計的血動力学指標.
- 線形回帰を用いて,血液動力指数と海馬体積,白質高強度体積,皮質厚み,脳アミロイド負荷 (PET) を相関させた.
主要な成果:
- より高い血液動力指数は,より健康的な脳血管機能を示し,より大きな海馬体積と関連していました.
- 改善された血液動力学指標は,ADの重要なバイオマーカーである脳下部のアミロイド負荷と相関しています.
結論:
- 脳血管機能障害は,アルツハイマー病において重要な役割を果たします.
- モデルベースの脳血液動力学の指標は,AD研究における臨床応用の可能性を示しています.
関連する概念動画
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...